Clinical trials
Withdrawn Premature Birth trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alabama at Birmingham | 4 |
| Philips Healthcare | 2 |
| University of California, Irvine | 2 |
| Brugmann University Hospital | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Children's Hospital of Fudan University | 1 |
| East Tennessee State University | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Hillel Yaffe Medical Center | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Premature Birth | 28 |
| Hypothermia | 3 |
| Respiratory Distress Syndrome | 3 |
| Birth Weight | 2 |
| Obstetric Labor, Premature | 2 |
| Abortion, Threatened | 1 |
| Abruptio Placentae | 1 |
| Anxiety Disorders | 1 |
| Feeding and Eating Disorders | 1 |
| Fetal Growth Retardation | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.